Genzyme Co. (GENZ) Hits New 52-Week High at $73.46 - American Banking News PDF Print
American Banking News
The Company's product and service portfolio is focused on rare genetic disease disorders, renal diseases, orthopaedics, cancer, transplant and immune

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.